1395 Piccard Drive
Suite 260A
Rockville, MD 20850
301-452-2899
Home
Product Candidates
Technology
Leadership
Contact
Home
Product Candidates
Technology
Leadership
Contact
Rclayton
About
Richard Clayton
This author has not yet filled in any details.
So far Richard Clayton has created 0 blog entries.
Recent Posts
Therabron Therapeutics Receives Orphan Drug Designation in the European Union for CG367.
Therabron Therapeutics to Present at Stifel 2016 Healthcare Conference
Therabron Therapeutics Receives from FDA Rare Pediatric Disease Designation for Lead Phase 2 Program in Preterm Infants
Therabron Therapeutics to Present at Upcoming Industry and Investor Conferences
Therabron Therapeutics Completes Enrollment of Phase 2 Clinical Trial for Lead Product Candidate CG100 for the Prevention of Chronic Lung Disease in Preterm Infants
Archives
January 2017
November 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
July 2015
May 2015
December 2014
March 2014
September 2012
December 2010
October 2010
March 2010
August 2009